Mannatech says it was misled by doctor

1999 LP Bloomberg with permission. On August 20, 1999 Mannatech Inc. said it has cut all ties to the California physician who wrote a now discredited medical journal article used by the nutritional supplements company to sell its pills. It now says Dr. Darryl See, the article’s author, backed his claims with false documents, and that it’s considering a lawsuit against him. Sees study ranked Mannatech’s pills, including its flagship Ambrotose, in the top five of 196 nutritional supplements tested. A company investigation confirmed a Bloomberg News report that Sees study was neither funded by the National Institutes of Health nor conducted under the auspices of the University of California at Irvine medical school, as it claimed. “We have disassociated ourselves completely and unequivocally from Dr. See,” said Samuel Caster, Mannatech’s president. “Unfortunately, Dr. See misrepresented himself and his work.” Mannatech also quoted from a Bloomberg News report in which Marikel Chatard, the technician who See said did most of the lab tests for the study, denied participating in it. The company said it verified Dr. Sees claims before using the his study. “We did everything we possibly could to ensure the material was authentic,” Caster added. That included paying $30,000 for an audit of Sees study, which it previously used to defend it. Bloomberg News reported that See never provided the laboratory notebooks requested by the auditor to authenticate his data.

Mannatech still hasn’t disclosed that it paid See more than $100,000 to speak at sale rallies and conduct research, and that his wife has been a Mannatech distributor since 1997, as See told Bloomberg in an interview. Mannatech sells its pills through an army of more than 400,000 distributors. Company executives weren’t available for comment. See resigned from the university’s faculty after an investigation censured him for violating research rules, including falsifying documents and conducting laboratory experiments on a rabbit without sufficient anesthesia. The Journal of the American Nutraceutical Association, which published Sees article, has stopped selling reprints of See’s articles, books and videotapes. See recommends Mannatech’s supplements for treatment of diseases such as AIDS and cancer in an audio cassette distributed by Mannatech. On Friday, Bloomberg News reported the NIH is investigating Mannatech’s relationship with Dr. Robert Ortmann, one of its scientists who is also a part-time Mannatech salesman. The agency ordered him not to appear at a company sales rally tomorrow in Olympia, Washington. Coppell, Texas-based Mannatech shares today fell 1/16 to 7 7/8. They’ve lost onethird of their value this month.

Copyright National Council for Reliable Health Information, Inc. Sep/Oct 1999

Provided by ProQuest Information and Learning Company. All rights Reserved

You May Also Like

Mannatech tells consumers & investors different tales

Mannatech tells consumers & investors different tales Evans, David Coppell, Texas, March 5 (Bloomberg). Mannatech Inc. tells consume…

Health reporting by 60 Minutes refereed

Health reporting by 60 Minutes refereed In a study by the American Council on Science and Health, each of 97 obtainable transcripts of hea…

Shark oil capsules contaminated with PCBS

Shark oil capsules contaminated with PCBS Five brands of shark oil capsules available over-the-counter internationally have been found to …

Nevada homeopaths scrap retry at expanding scope of practice

Nevada homeopaths scrap retry at expanding scope of practice Another short chapter has been written in the saga of one state’s flirtation …